A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Postherpetic Neuralgia (Protocol A0081224)
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Postherpetic Neuralgia (Protocol A0081224)
The purpose of the study is to explore the safety and efficacy of a new once a day pregabalin formulation versus placebo for patients with post herpetic neuralgia (Shingles)
Inclusion Criteria:
Exclusion Criteria:
San Diego, California 92117, United States
Chicago, Illinois 60657, United States
Sofia, 1202, Bulgaria
Sofia, 1431, Bulgaria
Bogota, Cundinamarca 0, Colombia
Prerov I, 750 02, Czechia
Kiel-Kronshagen, Schleswig-Holstein 24119, Germany
Lublin, Lublin Voivodeship 20022, Poland
Gdansk, Pomeranian Voivodeship 80286, Poland
Yaroslavl, Russian Federation 150023, Russia
Kazan', Tatarstan, Respublika 119992, Russia
Saint Petersburg, 197706, Russia
Bratislava, 851 07, Slovakia
Kwei Shan Town, Taoyuan County 333, Taiwan
Kharkiv, 61068, Ukraine
Vinnitsa, 21005, Ukraine